AlloVir (formerly ViraCyte) is a company that develops cell therapies for patients suffering from life-threatening virus-associated diseases.
Cullinan Oncology is an In-Licensing & Developing Oncology Assets for Sale founded in 2017.
TCR2 Therapeutics is a biotechnology company developing T cell hematologic cancer immunotherapies.